Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPT1A | P50416 | 20/20 | 0.73 |
| ▸ | CPT1B | Q92523 | 18/20 | 0.73 |
| ▸ | CPT2 | P23786 | 12/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL752125 | 0.94 | CPT1A (0.81) | CPT1ACPT1BCPT2 | |
| SCHEMBL753456 | 0.85 | CPT1A (0.74) | CPT1ACPT1BCPT2 | |
| SCHEMBL751312 | 0.85 | CPT1A (1.00) | CPT1ACPT1BCPT2 | |
| SCHEMBL750266 | 0.85 | CPT1A (0.82) | CPT1ACPT1BCPT2 | |
| SCHEMBL750910 | 0.84 | CPT1A (0.88) | CPT1ACPT1BCPT2 | |
| SCHEMBL752817 | 0.84 | CPT1A (0.76) | CPT1ACPT1BCPT2 | |
| SCHEMBL753435 | 0.83 | CPT1A (0.73) | CPT1ACPT1BCPT2 | |
| SCHEMBL754767 | 0.83 | CPT1A (0.73) | CPT1ACPT1BCPT2 | |
| SCHEMBL753527 | 0.81 | CPT1A (0.80) | CPT1ACPT1BCPT2 | |
| SCHEMBL754674 | 0.80 | CPT1A (0.80) | CPT1ACPT1BCPT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1996563-A1 | HETEROBICYCLIC SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES | F.HOFFMANN-LA ROCHE AG (CH) | 2008-12-03 | — | — | EP | claimed |
| WO-2007093507-A1 | HETEROBICYCLIC SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-23 | — | — | WO | claimed |
| EP-1996563-A1 | HETEROBICYCLIC SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES | F.HOFFMANN-LA ROCHE AG (CH) | 2008-12-03 | — | — | EP | disclosed |
| WO-2007093507-A1 | HETEROBICYCLIC SULFONAMIDE DERIVATIVES FOR THE TREATMENT OF DIABETES | F. HOFFMANN-LA ROCHE AG (CH) | 2007-08-23 | — | — | WO | disclosed |